TINY Notes - 記marker很易忘,但大原則是: 1. 不應一股腦兒全部都染,成本太高,也影響解讀。如果臨床H&P詳細,病理也不會太辛苦。 2. 不同的tumor可能會表現不同種的tumor marker,像是同樣是lung cancer,adenoma和small cell lung CA的表現就不同
![Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer | Nature Communications Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-22801-0/MediaObjects/41467_2021_22801_Fig1_HTML.png)
Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer | Nature Communications
![Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1044579X17300974-gr2.jpg)
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect
Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer | PLOS ONE
![A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer - eBioMedicine A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer - eBioMedicine](https://www.thelancet.com/cms/asset/dad903af-a690-43e5-8b6a-f2252ff25e5f/gr1.jpg)
A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer - eBioMedicine
Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers | PLOS ONE
Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer | PLOS ONE
![Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research](http://www.cjcrcn.org/data/pic/3347_0.png)
Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research
![Table 2 from SRSF 5 : a novel marker for small-cell lung cancer and pleural metastatic cancer Short title : SRSF 5 protein is a new SCLC marker | Semantic Scholar Table 2 from SRSF 5 : a novel marker for small-cell lung cancer and pleural metastatic cancer Short title : SRSF 5 protein is a new SCLC marker | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3eb8aeb3ef0e5fbd41ccaac4c356ef547e9dadef/22-Table2-1.png)